PIBAN can have side effects. Not all side effects reported for PIBAN are included in this leaflet. Should your general health worsen or if you experience any untoward effects while using PIBAN, please consult your healthcare provider for advice.
If any of the following happens, stop using PIBAN and tell your doctor immediately or go to the casualty department at your nearest hospital:
- swelling of the hands, feet, ankles, face, lips and mouth or throat, which may cause difficulty in swallowing or breathing,
- raised and itchy rash,
- collapse.
These are all very serious side effects. If you have them, you may have had a serious reaction to PIBAN. You may need urgent medical attention or hospitalisation.
Tell your doctor immediately or go to the casualty department at your nearest hospital if you notice any of the following:
- infection and inflammation of the large intestine (pseudomembranous colitis), causing diarrhoea, usually with blood and mucous, stomach pain and fever. These are all serious side effects. You may need urgent medical attention.
Tell your doctor if you notice any of the following:
Frequent side effects:
- Burning where the ointment is applied.
Less frequent side effects
- Itching, redness, stinging and dryness on your skin in the place where PIBAN is applied.
- Allergic rash, itching, redness or soreness of the skin can also occur on other parts of your body.
Frequency not known
- Superinfection of the skin by germs resistant to PIBAN may develop if PIBAN is used for a long time. If this occurs, tell your doctor, pharmacist or nurse.
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Reporting of side effects
If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of PIBAN.